Clinicopathological changes in patients after anti-TNFα therapy.

CD31+/aSMA–: immature vessels. CD31+/aSMA+: mature vessels. p-value of basal versus post-anti-TNF values.

(*)Absolute decrease from basal values in patients achieving moderate or good EULAR response (responders) and non responders to anti-TNF.

Categories

Keyword(s)

License

CC BY 4.0